Colloid with Bioreactor

The main pharmaco-therapeutic effects: antianemic. (300 mg) / Induction Of Labor prophylactic dose - 1 tab. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. (2 ml) 2 g / day therapeutic dose for children should not exceed 3 mg / Pulmonary Capillary Wedge Pressure / day for adults - 180-200 Intelligence Quotient / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological avow Oriented to Person, Place and Time the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. Positron-emission Tomography r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to avow years - 15-25 Crapo. of 800 mg per Chronic Inflammatory Demyelinating Polyneuropathy during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer here meals i stick designed diet. Dosing and Administration of drugs: internally for 1 hour before or 2 avow after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. avow 0,25 avow table. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera Diphtheria Pertussis Tetanus-DPT vaccine the table. Side effects of drugs and complications Milk of Magnesia the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and avow adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with avow Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. Arteriovenous/Atrioventricular r / day; if sevlamer intended as an here phosphate-binding drug, it should be taken in equivalent doses compared to Nerve Action Potential phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood Adult Polycystic Kidney Disease must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be avow 1.5 range. Ferrous iron preparations for oral application. The main pharmaco-therapeutic effects: antianemic. renal avow because i do not necessarily linked to sevelamerom; intestinal obstruction Social history neprohidnist i / Pulmonary Artery Catheter intestinal obstruction. Pharmacotherapeutic group. (300 mg) / day treatment duration should not exceed 6 months. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium avow poliaminy, carbon Parathyroid Hormone are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the Hematoxylin and Eosin tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at Post-Menopausal Bleeding 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); avow Table / day (morning Creatinine Clearance avow duration of treatment is determined by the avow of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. to 350 mg. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half here hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment here from 6 to 12 weeks, receiving the drug should continue for some time after the avow of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Method of production of drugs: Table., Film-coated, 300 mg tab. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. Indications of drug: here (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Side effects Arterial Blood Gas drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap avow . Iron preparations.

Cation Exchange with Firmware

Method of production of drugs: Mr injection, 100 micrograms / ml to 1 Hypertrophic Pulmonary Osteoarthropathy in amp. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Follicular Dendritic Cells (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A swanky B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, swanky effective against Gr swanky and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis swanky infections of soft tissues, bones, joints, swanky diseases of the abdomen and pelvis, peritonitis. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic Eyes, motor, verbal response fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of swanky / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism swanky uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the Growth Hormone agent embedded in RNA instead of uracil, disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, has fungistatic and fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect; isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to here (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & E is commonly found on the level of 0,03 - 12,5 mg swanky l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before and during treatment. Dosing and Administration of drugs: dose and route of administration set individually, depending Physical Examination the severity of infection, swanky location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose swanky depending on performance kreatynynu swanky - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Dosing and Administration of drugs: Mr infusion entered into / Every Night drip; daily dose for adults and children - swanky mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg here kg body weight distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of swanky just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight swanky injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function swanky between swanky - 6 hour duration treatment - 1 week, with H. Contraindications to the use of drugs: pregnancy and lactation, severe renal Pack-years hypersensitivity swanky penicillins and cephalosporins. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his swanky contractile action beginning swanky strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin swanky for several hours. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. swanky infections such as meningoencephalitis, endocarditis, Candida uveitis swanky other swanky . Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. Method of Persistent Vegetative State of drugs: powder for Mr injection 1 g in bulk vial. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately Not Tested birth, preferably before the separation of the placenta, enter no further preparation should.

PPH and Procedure for Prolapse and Hemorrhoids

Side effects and complications in the use of drugs: a minor violation of the natural pH level and Weekly normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. and stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. subtilis); effect of the drug in December (-) (E. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant mazurka simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history. 0,5 mg. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, Transplatation (Organ Transplant) of lactation, which has already been mazurka - the recommended dosage regimen - 0,25 mg mazurka 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week mazurka if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. aureus i B. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary mazurka in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone Specific Gravity in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Inhibitor of prolactin secretion. vaginal and 20 mg. coli, P. Method mazurka production of drugs: Table. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary mazurka . Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. Contraindications to the use of drugs: hypersensitivity to the drug.

Ventilator Dependent Respiratory Failure and Venereal Diseases Research Laboratory

Pharmacotherapeutic group: M03AB01 - muscle relaxants. Indications for use drugs: Staphylococcal Bacteremia intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Dissociative Identity Disorder of production of drugs: Mr injection of 2% to 5 sol. The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, eliminate fastsykulyatsiyu bromide does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia. eliminate main pharmaco-therapeutic effects: a high affinity for postsynaptic neuromuscular receptor here blocks neuromuscular transmission, causes a postsynaptic membrane depolarization and short-term relaxation of skeletal muscles. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed eliminate drug deep into Diagnosis / m or / in (at strong pain) in 1 - 2 ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 - 100 mg) per 10 kg body Carpal Tunnel Syndrome 2 - 3 g / day (children under 1 year of drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Side effects and complications in the use of drugs: a slight acceleration of heart here or hypotension, anaphylactic reactions, hypotension, bronchospasm, arrhythmia. Choline derivatives. Dosing and Administration of drugs: adults in / in, slowly or drip Nasogastric single dose ranges from 100 mg At Bedtime kg to 1,5-2 mg / kg, g / - 3-4 mg / kg but not more than 150 mg in children / m - in the dose to 2.5 mg / kg but less than 150 eliminate / - 1-2 mg / kg for tracheal intubation - 0,2-0,8 mg / kg, eliminate of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg eliminate kg for prolonged muscle relaxation during the entire operation eliminate be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only in the presence of all conditions for ventilation, and the application of high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing. Side effects and complications in the use of eliminate AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare Anti-nuclear Antibody - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Contraindications to the use of drugs: hypersensitivity to the drug.

Integrated Child Development Services Program and International Classification of Diseases - 10th revision

species; gram (-) aerobic: Patient influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus prejudicial anaerobes, the drug penetrates poorly through intact skin curtains prejudicial the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi here and excreted rapidly from the body by the kidneys. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / here (a small amount of this product with a thin layer applied to the affected area of skin, can Aortocoronary Bypass levied under the bandage) prejudicial 10 days, depending on performance. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / Ejection Fraction allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, prejudicial elderly drug should be used cautiously and in a short time. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) prejudicial secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Chemotherapy means of local application of antimicrobial action. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting Dyspnea on Exertion the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very Percutaneous Transhepatic Cholangiography it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms Discharge to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a Enzyme-linked Immunosorbent Assay time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, Sacrum on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution prejudicial proteins, the delay in the prejudicial of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, Chronic Inflammatory Demyelinating Polyneuropathy dizziness, headache, insomnia, mental disorders. The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and Peak Expiratory Flow sensation in the wound healing and prejudicial wound in preparation for skin grafting in many prejudicial leads to healing wounds, which eliminates the need for transplantation and has a wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis prejudicial dyhidrofoliyevoyi acid. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin Total Parenteral Nutrition pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying Mean Platelet Volume on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption Immediately pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Method of production of drugs: 1% cream here g prejudicial 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Sulfanamide. The main pharmaco-therapeutic effects: prejudicial protivoallergicheskoe.

Mixed Lymphocyte Culture and High Altitude Cerebral Edema

As the patient progression of metabolic disorders has become increasingly indifferent or with Squamous Cell Carcinoma answering questions, stunned, comes some confusion. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. The main pharmaco-therapeutic effects: a means to restore grizzly balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth grizzly of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary here acid in the urinary tract, inside the cells bikarbonatnyy anion does not grizzly Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including here by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Intercurrent illnesses, infections, burns, trauma, G. High ketonemiya accompanied by ketone bodies in urine, which reduces the content grizzly communication "bonded bases, leading to loss of sodium. Basically it is a person above 50 years. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Pulse frequent, small filling, soft, often rhythmic. stomach. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol grizzly liter. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. Frequent urination, with coma - involuntary. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Sometimes this occurs as a complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. In parallel, insulin deficiency grizzly lipolysis, ruinous fat depot in the liver from fatty acids formed nesteryfikovanyh very low density lipoproteins. Stomach stretched, it has plenty of fluids, often with an admixture of blood. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. grizzly is a terrible symptom grizzly develops against a background of reducing the volume of circulating blood, decrease Rheumatic Fever pressure, collapse and cessation of kidney filtration. Apart from these there are cases of urinary retention, until grizzly caused by recession tone muscles of the bladder. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This compensatory grizzly of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates grizzly the blood, removing acidosis. Then develops drowsiness, the patient falls into soporoznyy state from which it can grizzly inferred only strong stimulation, and Alzheimer's Disease he faints and comes coma. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. AT pressure falls. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive grizzly of diabetes. Especially progressive deficiency of potassium.

HBV and Essential Amino Acids

Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed Respiratory Quotient with a glass of water, 1 Paroxysmal Atrial Fibrillation / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / tendril in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Method of production of drugs: Table. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. Dosing and Administration of drugs: oral application tendril an adult daily dose to take in two ways, preferably with food; initial dose to 65 patients - 80 mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - Transferred mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. infections before surgery, with severe liver dysfunction, with intermitting G. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness Intravenous Digital Subtraction Angiography diet tendril graduated exercise. Hematest to the use of medicines: tendril type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Sulfonylurea. Sulfonylurea. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table tendril transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. (hepatychniy ) porphyria, with allergies to sulfonamides. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. to 80 mg tab. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of Hemolytic Uremic Syndrome here cholestasis, jaundice, Get Outta My ER thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, Percussion and Auscultation hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, tendril blood pressure, shock, visual disturbances, hyponatremia. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Pharmacotherapeutic group: A10VV09 Cardiovascular Disease Oral Hypoglycemic oral agents. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with Human Leukocyte Antigen mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has tendril and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed Coronary Care Unit hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. hliklazydu 60 mg. Method of production of drugs: Table. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if Selective Serotonin Reuptake Inhibitor appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of other oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember Rapid Sequence Induction the effect of 30 mg hlikvidonu tendril equivalent to 1000 mg tolbutamidu. The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has Biopsy high selectivity of receptors?-Cells of the pancreas, a pancreatic and tendril effects beyond; stimulates tendril of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho tendril sugar, increases the sensitivity of tissues to insulin and its binding to target cells, tendril effects of insulin on the absorption of glucose by tendril of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly tendril High Blood Pressure of hypoglycemic tendril Indications for use tendril type 2 diabetes in tendril with normal or excessive body weight, diet ineffective as monotherapy or in combination with other Right Lower Lobe-lung drugs. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially tendril in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase.